# XENiOS

> XENiOS is a VC fund in Heilbronn backing Medical and Health Care. See 2 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: VC Fund
- Location: Heilbronn, Germany
- Total investments: 2
- Last investment: Sep 2016
- Lead investor: 0%
- Last updated: Sep 2026
- LinkedIn: https://www.linkedin.com/company/xenios-ag
- Website: https://www.xenios-ag.com/

XENiOS is a VC fund in Heilbronn focused on Medical and Health Care. XENiOS AG developer of extracorporeal therapy systems., because the heart and the lungs are linked anatomically the right heart (ventricle) perfuses the lungs, while the left heart (ventricle) perfuses the body. No other company except XENIOS AG is offering minimally invasive disposable lung and heart therapies on one single platform.

## Contacts

5 contacts available for XENiOS. Shizune tracks 5 team members at XENiOS. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/xenios-ag?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Health Diagnostics | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Dr. Benjamin Waldmann | CEO | 0 | — |
| Georg Matheis | Managing Director | 0 | — |
| Josef Bogenschuetz | CEO & President | 0 | — |
| Jurgen Bohm | Managing Directo, Chief Marketing and Medical Officer | 0 | — |
| Knut Jöchle | Vice President - Product Life Cycle & Quality Processes | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| XOR Labs Toronto | Advances in medical science have introduced the era of personalized medicine for organs. XOR Labs Toronto is a pioneer in this field. We are changing the face of organ transplantation by exponentially increasing the number of donated lungs available for transplantation around the world. | $2.2M | Venture - Series Unknown | Sep 21, 2016 | http://xorlabstoronto.com/ |
| XOR Labs Toronto | Advances in medical science have introduced the era of personalized medicine for organs. XOR Labs Toronto is a pioneer in this field. We are changing the face of organ transplantation by exponentially increasing the number of donated lungs available for transplantation around the world. | $1.9M | Venture - Series Unknown | Feb 22, 2016 | http://xorlabstoronto.com/ |

2 of 2 investments shown.

## Co-investors
- [Toronto Innovation Acceleration Partners](https://shizune.co/investors/profile/mars-innovation-mi) — VC Fund, 1 deal together
- [Regenesis Limited Partnership](https://shizune.co/investors/profile/regenesis-limited-partnership) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## FAQ

### What does XENiOS invest in?

XENiOS invests primarily in Medical, Health Care and Health Diagnostics startups, most often at Venture - Series Unknown stage. Most of the 2 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact XENiOS?

Public channels for XENiOS include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at XENiOS?

The team at XENiOS includes Dr. Benjamin Waldmann (CEO), Georg Matheis (Managing Director) and Josef Bogenschuetz (CEO & President). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co